The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden.

Guangzhou Daan Gene Co., Ltd., established on 1988-08-17, Business scope includes agricultural scientific research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Medical equipment rental;Development of Human Gene Diagnosis and Therapy Technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;R&D and application of cell technology;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;General machinery and equipment installation services;Special Equipment Repair;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Professional Design Services;software development;Machinery sales;Mechanical Parts,Parts sales;Engage in investment activities with own funds;Engineering Management Services;Refrigeration,Air Conditioning Equipment Manufacturing;General Equipment Repair;Auto New Car Sales;housing lease;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Inspection and testing service;Residential interior decoration;Import and export;Securities Investment Consulting;Construction Engineering Construction

United Medicine is working on integrated solutions for in vitro diagnostic reagents and instruments. They offer infectious disease diagnosis solutions such as multiplex PCR, NGS rapid, pathogen screening reagents, flow cytometry multiple cytokine detection reagents, and automated fluorescence detection technology. They also provide a diagnosis for female vaginitis.

Syntonix discovers and develops novel, long-acting, proprietary therapeutic products using the company’s proprietary Fc-fusion proteins and other engineered ligands which bind to specific Fc receptors. These technologies, including Syntonix’ drug delivery platform technology Transceptor™, harness the body’s natural pathways for protecting antibodies against premature destruction and for transporting antibodies across cell barriers such as those in the lungs and intestines. Syntonix focuses on using these technologies to create next generation treatments for devastating chronic diseases such as hemophilia, anemia, and autoimmune disorders. Syntonix develops selected products for specialty indications, such as hemophilia, on its own. Other products will be evaluated and commercialized through partnerships with companies with established market positions. The company is headed by an experienced management team and has focused initially on using its proprietary technology to enhance existing drugs with proven safety, efficacy, and economic return. Syntonix currently occupies a 25,000 square foot state-of-the-art laboratory facility, including a cGMP clinical manufacturing suite, in Waltham, Massachusetts.

NHC Communications, Inc. manufactures network switching and test equipment for local telecom service providers, corporations and multi-tenant buildings. It also offers the XPoint product line geared for smaller network applications. The company was founded in 1986 and is headquartered in Mount-Royal, Canada

Shanghai Berger Medical Technology Co., Ltd., established on 2017-03-01, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Instrument sales;Health Consulting Services(Does not include medical services);Data processing and storage support services;Conference and Exhibition Services;Auto New Car Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuhan Mingluo Biotechnology Co., Ltd., established on 2019-01-07, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting;Laboratory reagents and consumables(Free of Hazardous Chemicals),Testing instruments and equipment,Technology development of computer hardware and software,technology transfer,technical consulting;Information system integration service;Instrumentation(Does not include measuring instruments),Office Supplies,Chemical Products(Does not contain hazardous chemicals),Sales of laboratory equipment;Inspection and testing service(Operate within the approved period with the license);data processing;Import and export of goods or technology(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).

Beijing Yuansheng Kangtai Gene Technology Co., Ltd., established on 2019-07-02, Business scope includes human genetic diagnosis and treatment,biological technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;software development;Basic software service;Application software service;Computer System Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.4Except for the above cloud computing data centers);market survey;Conference Services;Undertake exhibition and display activities;Business Management Consulting;Economic and Trade Consulting;Cultural Consulting;public relations service;Medical Research and Experimental Development;Natural science research and experimental development;selling computers,Software and Auxiliary Equipment,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),Equipment,self-developed product,medical instrumentsI,IIkind,office equipment(Do not engage in physical store operations);design,make,acting,Place an ad;model design;product design;Import and export;Specialty Chemicals Sales.(Market entities independently choose business projects in accordance with the law,Carry out business activities;and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain.

Hangzhou Zhiyuan Medical Laboratory Co., Ltd., established on 2005-06-08, Business scope includes services:Medical Laboratory,clinical microbiology major,Medical Research Technology,Medical Diagnostic Products,Development of new drugs,Achievement transfer;All other legal items that do not need to be submitted for approval.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Aquilon Pharmaceuticals SA provides biotechnology research and development services. The company was founded by Didier Cataldo, Brigitte Evrard, and Francois Boitquin in 2013 and is headquartered in Vise, Belgium.

X-ABT is a tech enterprise that provides solutions for pathogenic microorganism detection in the medical and health fields. The company focuses on providing complete solutions for the detection of infectious pathogens in the medical and health field. They develop and produce systems for disease control, prevention, clinical hospitals, and entry-exit customs. X-ABT also provides clinical marketing and sales services to help medical workers and serve patients.